SCHEMBL19620635

SCHEMBL19620635

NC1=C(OS(=O)Cc2ccccc2)C(=O)C(c2ccnc3ccccc23)O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
PTK2B Q14289 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C19 P33261 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
BRCA1 P38398 1/20 0.34
KMT2A Q03164 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NCF1 P14598 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19620504 0.80 TP53 (0.43) TP53MAPTNPC1RAB9APTK2B
SCHEMBL29852012 0.79 MAPT (0.43) TP53MAPTNPC1RAB9APTK2B
SCHEMBL15627554 0.79 MAPT (0.43) TP53MAPTNPC1RAB9APTK2B
SCHEMBL19620621 0.78 MAPT (0.49) TP53MAPTRAB9ASMN1; SMN2CYP1A2
SCHEMBL19620692 0.78 DPP4 (0.38) MAPTSMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL19620539 0.78 CYP1A2 (0.33) MAPTCYP1A2CYP3A4CYP2C19KDM4E
SCHEMBL20367966 0.77 TOP2A (0.35) MAPTNPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL19620671 0.77 MAPT (0.40) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL19620531 0.76 MAPT (0.39) TP53MAPTCYP3A4KDM4EALDH1A1
SCHEMBL19620732 0.76 MEN1 (0.33) MAPTKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2897607-B1 INHIBITORS OF BETA-HYDROLASE FOR TREATMENT OF CANCER RHODE ISLAND HOSPITAL (US) 2017-11-22 EP disclosed